High-density lipoproteins neutralize C-reactive protein proinflammatory activity

Area of Science:

• Cardiovascular Biology
• Inflammation Research
• Lipid Metabolism

Background:

• C-reactive protein (CRP) is a marker of atherosclerosis with suggested direct pro-inflammatory effects.
• A natural factor to neutralize CRP's effects has been hypothesized but not identified.
• CRP induces inflammatory adhesion molecules in endothelial cells.

Purpose of the Study:

• To investigate the potential inhibitory effect of high-density lipoprotein (HDL) on CRP-induced inflammation.
• To elucidate the mechanism by which HDL might counteract CRP's pro-inflammatory actions.

Main Methods:

• Assessed CRP-induced upregulation of inflammatory adhesion molecules in human umbilical vein endothelial cells (HUVECs).
• Evaluated the inhibitory effects of native HDL and reconstituted HDL (rHDL) on CRP-induced adhesion molecule expression.
• Identified the active component within HDL responsible for the inhibitory effect.

Main Results:

• CRP significantly upregulated inflammatory adhesion molecules at both protein and mRNA levels in HUVECs.
• HDL, both native and reconstituted, completely suppressed CRP-induced adhesion molecule expression.
• Reconstituted HDL (rHDL) was 100 times more potent than native HDL, and oxidized phospholipids were identified as the key active component.

Conclusions:

• HDL effectively prevents CRP-induced upregulation of inflammatory adhesion molecules in endothelial cells.
• The inhibitory mechanism involves HDL's oxidized phospholipid components.
• HDL represents a potential therapeutic target for mitigating CRP-driven inflammation in atherosclerosis.